SuperworthCartesian Therapeutics shares outstanding RNAC
Diluted shares outstanding, averaged over each quarter, from 2015.
- Latest quarter, to Jun 30, 2026
- 29.9M
- On a year earlier
- +12.9%
- more shares
Cartesian Therapeutics had 29.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 12.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 26M | +3% |
| FY2024 | 25.4M | +379% |
| FY2023 | 5.3M | +4% |
| FY2022 | 5.1M | +29% |
| FY2021 | 3.9M | +9% |
| FY2020 | 3.6M | +106% |
| FY2019 | 1.7M | +133% |
| FY2018 | 748.4K | +1% |
| FY2017 | 742.3K | +22% |
| FY2016 | 608.9K | +743% |
| FY2015 | 72.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 29.9M | +13% | |
| Q1 FY26 | 26.9M | +4% | |
| Q4 FY25 | 26M | +3% | |
| Q3 FY25 | 26M | +21% | |
| Q2 FY25 | 26.4M | +49% | |
| Q1 FY25 | 25.9M | +378% | |
| Q4 FY24 | 25.4M | +379% | |
| Q3 FY24 | 21.5M | +316% | |
| Q2 FY24 | 17.8M | +248% | |
| Q1 FY24 | 5.4M | +6% | |
| Q4 FY23 | 5.3M | +4% | |
| Q3 FY23 | 5.2M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cartesian Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.